Speech-Language Pathologists in Florham Park, NJ Accepting Medicare

7 Speech-Language Pathologists found. Showing 1 - 7

Jinnie Ann James, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8 James St, Florham Park, NJ 07932 Phone: 862-465-0086

Caryn Beth Badian Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 905 Sun Valley Way, Florham Park, NJ 07932 Phone: 973-868-3154

Kalliopi Kebabjian, MS CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5406 Darling Dr, Florham Park, NJ 07932 Phone: 973-525-4214

Miss Tara Rozlyn Orangeo Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18 Midwood Dr, Florham Park, NJ 07932 Phone: 973-820-5713

Speechabilities Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 79 Roosevelt Blvd, Florham Park, NJ 07932 Phone: 201-213-2580

Ms. Edith Robin Picon, MA,CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2 Country Club Ln, Florham Park, NJ 07932 Phone: 973-377-6316

Speech At Play Therapy Center, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 248 Columbia Tpke Ste 103, Florham Park, NJ 07932 Phone: 973-520-8501

News Archive

Seventh Wave announces collaboration with Yecuris to study new liver disease therapies

Seventh Wave Laboratories, a consulting-based contract research organization that assesses the safety and efficacy of pharmaceutical products and medical devices, has announced an exclusive collaboration with Yecuris Corporation, a global leader in the development and use of humanized models in drug development research.

Researchers develop a machine learning-based screening tool for genetic syndromes in children

With an average accuracy of 88%, a deep learning technology offers rapid genetic screening that could accelerate the diagnosis of genetic syndromes, recommending further investigation or referral to a specialist in seconds, according to a study published in The Lancet Digital Health.

Abiraterone acetate improves survival in metastatic castration-resistant prostate cancer

Patients with metastatic castration-resistant prostate cancer who have progressed after chemotherapy live significantly longer if treated with the drug abiraterone acetate compared to placebo, the results of a large Phase-III clinical trial confirm.

"Our request for information gets denied by Governor's office": AWF Executive Director Brian Johnson

Last week, the Alliance for Worker Freedom (AWF) called on Kansas Gov. Mark Parkinson (D) to release financial documents and correspondence surrounding his Departments using taxpayer money and state resources to collect healthcare provider names and addresses for the Service Employee International Union (SEIU).

Read more Medical News

› Verified 9 days ago